[Hil Medical in PR Newswire] HIL Medical and Proton International awarded $900k grant from the BIRD Foundation to advance an ultra-compact, affordable proton beam therapy solution for cancer

HIL Medical, a global leader in developing a new class of Proton Therapy systems, together with its partner Proton International (P.I.), announced today that the companies have been awarded a $900K grant from the Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation. The BIRD Foundation supports cooperation between U.S. and Israeli companies for developing joint products or technologies in a wide range of technology sectors that are of mutual benefit to the U.S. and Israel.